Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion description "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion evidence source_evidence_literature NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion SIO_000772 18447716 NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion wasDerivedFrom befree-2016 NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion wasGeneratedBy ECO_0000203 NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- befree-2016 importedOn "2016-02-19" NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.